Table: begin end state 1 6 cytoplasmic 7 8 signal peptide 9 27 transmembrane 28 33 non-cytoplasmic 34 53 transmembrane 54 92 cytoplasmic 93 113 transmembrane 114 118 non-cytoplasmic 119 140 transmembrane 141 160 cytoplasmic 161 184 transmembrane 185 190 non-cytoplasmic 191 210 transmembrane 211 221 cytoplasmic 222 242 transmembrane 243 255 non-cytoplasmic 256 277 transmembrane 278 284 cytoplasmic 285 304 transmembrane 305 325 non-cytoplasmic 326 346 transmembrane 347 365 cytoplasmic 366 386 transmembrane 387 465 non-cytoplasmic 466 485 transmembrane 486 510 cytoplasmic 511 530 transmembrane 531 542 non-cytoplasmic 543 567 transmembrane 568 573 cytoplasmic 574 596 transmembrane 597 641 non-cytoplasmic 642 664 transmembrane 665 686 cytoplasmic
Input: >Pf6N2E2_1294 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_1294 MTTRLVKHLAWFAVAVLGGCALSVVALRRGEPINALWIVVAAVAIYLVAYRYYSLFIANN VMQLDARRATPAVLNNDGLDYVPTNKHILFGHHFAAIAGAGPLVGPVLAAQMGYLPGTLW LIAGVVLAGAVQDFMVLFLSTRRNGRSLGDMVREEMGRIPGTIALFGCFLIMIIILAVLA LIVVKALAESPWGIFTVMATIPIAMFMGIYMRYIRPGRIGEISVIGVLLLLGSIWLGGQI AADPVWAKAFTFTGIQITWMLIGYGFVAAVLPVWLILAPRDYLSTFLKIGTIVALAIGIL VTMPELKMPALTQFTDGTGPVWKGGLFPFLFITIACGAVSGFHALISSGTTPKLLDNETN ARYIGYGGMLMESFVAIMAMVAASVIEPGVYFAMNSPAAIVGGDVVAVAQTVSSWGFAIT PEALQAVAKDIGETTVLARAGGAPTLAVGIAQILHSVLPGENTMAFWYHFAILFEALFIL TAVDAGTRAGRFMLQDLLGSFVPALKRTESWTANLIATAGCVALWGYLLYQGVIDPLGGI NTLWPLFGISNQMLAGIALMLATVVLIKMKRQRYVWVTLLPASWLLICTTTAGLIKLFDA NPAIGFLALARKYNDALAAGQVLAPAKSIEQMQHVVFNAYTNATLTVLFLFVVFSILFYA LKVGIAAWGTKERTDKEAPFQAVPDA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server